ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Caixin

China drugmaker inks deal to produce Russia's Sputnik V for export

Hualan Biological Engineering expects orders for at least 100 million doses

Hualan said its vaccine unit's deal includes a technology transfer agreement that will provide the necessary capabilities to make the inoculation.   © Reuters

The vaccine arm of Hualan Biological Engineering will be the first Chinese company to produce Russia's promising COVID-19 vaccine, Sputnik V, the company said.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more